These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 8120277)

  • 41. Bortezomib can suppress activation of rapamycin-resistant memory T cells without affecting regulatory T-cell viability in non-human primates.
    Kim JS; Lee JI; Shin JY; Kim SY; Shin JS; Lim JH; Cho HS; Yoon IH; Kim KH; Kim SJ; Park CG
    Transplantation; 2009 Dec; 88(12):1349-59. PubMed ID: 20029331
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition by rapamycin of P-glycoprotein 170-mediated export from normal lymphocytes.
    Yacyshyn BR; Bowen-Yacyshyn MB; Pilarski LM
    Scand J Immunol; 1996 Apr; 43(4):449-55. PubMed ID: 8668925
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immunological features of steroid-resistant asthma].
    Sun Y; Luo W; Zhu Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Feb; 20(1):12-5. PubMed ID: 10072794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapamycin inhibits aldolase A expression during human lymphocyte activation.
    Wang X; Luo H; Perks A; Wu J
    J Cell Biochem; 1996 Nov; 63(2):239-51. PubMed ID: 8913875
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of upper respiratory infection on T-cell proliferation and steroid sensitivity of asthmatics.
    Vianna EO; Westcott J; Martin RJ
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):592-7. PubMed ID: 9802366
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Asthma refractory to glucocorticoids: the role of newer immunosuppressants.
    Corrigan CJ
    Am J Respir Med; 2002; 1(1):47-54. PubMed ID: 14720075
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of IL-5 expression by IL-2 is resistant to the immunosuppressive agents cyclosporin A and rapamycin.
    Valentine JE; Sewell WA
    Int Immunol; 1997 Jul; 9(7):975-82. PubMed ID: 9237106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of rapamycin on the expression of the IL-2 receptor (CD25).
    Woerly G; Brooks N; Ryffel B
    Clin Exp Immunol; 1996 Feb; 103(2):322-7. PubMed ID: 8565319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Divergent effects of rapamycin on mouse and rat cells following mitogenic stimulation.
    Olivera DL; Kaplan JM; Newman-Tarr T; Ruggieri EV; Badger AM
    Clin Immunol Immunopathol; 1993 Sep; 68(3):357-62. PubMed ID: 7690317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin-2 receptor (CD25) upregulation on human T-lymphocytes: sensitivity to immunosuppressants is defined by the mode of T-lymphocyte activation.
    Ryffel B; Willcocks JL; Brooks N; Woerly G
    Immunopharmacology; 1995 Sep; 30(3):199-207. PubMed ID: 8557519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pentoxifylline potentiates in vitro lymphocyte suppression by glucocorticoids and immunosuppressive drugs.
    Briggs WA; Eustace J; Mathew S; Gimenez LF; Choi M; Scheel PJ; Burdick J
    J Clin Pharmacol; 1998 Jun; 38(6):561-6. PubMed ID: 9650547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of cyclosporine and Sirolimus on interleukin-15-driven proliferation of OKT3-preactivated human lymphocytes.
    Degiannis D; Kalteziotis V; Thalassinos A; Kapsalis A; Kroupis C; Koniavitou K
    Transplant Proc; 1998 Jun; 30(4):948-9. PubMed ID: 9636382
    [No Abstract]   [Full Text] [Related]  

  • 53. The actions of cyclosporin A and FK506 on T-lymphocyte activation.
    Mattila PS
    Biochem Soc Trans; 1996 Feb; 24(1):45-9. PubMed ID: 8674715
    [No Abstract]   [Full Text] [Related]  

  • 54. Autoimmune pancreatitis in MRL/Mp mice is a T cell-mediated disease responsive to cyclosporine A and rapamycin treatment.
    Schwaiger T; van den Brandt C; Fitzner B; Zaatreh S; Kraatz F; Dummer A; Nizze H; Evert M; Bröker BM; Brunner-Weinzierl MC; Wartmann T; Salem T; Lerch MM; Jaster R; Mayerle J
    Gut; 2014 Mar; 63(3):494-505. PubMed ID: 23564336
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of in vivo and in vitro glucocorticoid sensitivity in depression: relationship to the dexamethasone suppression test.
    Lowy MT; Reder AT; Gormley GJ; Meltzer HY
    Biol Psychiatry; 1988 Oct; 24(6):619-30. PubMed ID: 3262379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus.
    Khanna AK
    Transplantation; 2000 Aug; 70(4):690-4. PubMed ID: 10972232
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of T and B lymphocyte proliferation by rapamycin.
    Kay JE; Kromwel L; Doe SE; Denyer M
    Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients.
    Xystrakis E; Kusumakar S; Boswell S; Peek E; Urry Z; Richards DF; Adikibi T; Pridgeon C; Dallman M; Loke TK; Robinson DS; Barrat FJ; O'Garra A; Lavender P; Lee TH; Corrigan C; Hawrylowicz CM
    J Clin Invest; 2006 Jan; 116(1):146-55. PubMed ID: 16341266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapamycin inhibits p34cdc2 expression and arrests T lymphocyte proliferation at the G1/S transition.
    Flanagan WM; Crabtree GR
    Ann N Y Acad Sci; 1993 Nov; 696():31-7. PubMed ID: 8109837
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo and in vitro effects of glucocorticoids on lymphocyte proliferation in man: relationship to glucocorticoid receptors.
    Rupprecht R; Wodarz N; Kornhuber J; Schmitz B; Wild K; Braner HU; Müller OA; Riederer P
    Neuropsychobiology; 1990-1991; 24(2):61-6. PubMed ID: 1966869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.